GlassScriptPhysician profile
Gregory Odell
NPI 1578656849
$906.09
in general payments reported to CMS, 2019-2025
13 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $180 · 2021: $149 · 2022: $14.49 · 2023: $15.27 · 2024: $62.94 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $214.30 | 2019-2025 | |
| Sanofi Pasteur INC. | $125.51 | 2020-2025 | |
| Genentech USA, INC. | $111.42 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $106.75 | 2019-2025 | Rotateq, Gardasil 9, Vaxneuvance |
| Kaleo, INC. | $80.09 | 2020-2024 | Auvi-Q |
| Ironshore Pharmaceuticals INC. | $77.66 | 2019-2021 | |
| Tris Pharma INC | $51.63 | 2019-2025 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $39.69 | 2020-2021 | |
| Adlon Therapeutics L.P. | $30.73 | 2020-2021 | |
| Alk-Abello, INC | $21.12 | 2025 | Neffy, Odactra |
| Shire North American Group INC | $21.05 | 2019 | |
| Cranial Technologies, INC | $14.20 | 2021 | |
| Genzyme Corporation | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Odell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.